Clinical Trial Update: Pregnancy Exposure Registry for Tysabri®

View source ↗

Summary

The Pregnancy Exposure Registry for natalizumab (Tysabri) has completed data collection, documenting outcomes in patients with Crohn's disease and multiple scle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Crohn's Disease, Prenatal Exposure | Status: COMPLETED